サマリー

市場の分析と洞察。がん免疫調整剤の世界市場
COVID-19の大流行により、がん免疫調整剤の世界市場規模は2022年に百万米ドルと推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、使用方法：2021年にがん免疫調整剤の世界市場の％を占めたCoQ10は、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に改訂された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。
中国のがん免疫調整剤の市場規模は2021年に百万米ドル、米国と欧州のがん免疫調整剤はそれぞれ百万米ドル、百万米ドルと評価されています。2021年における米国の割合は%であり、中国と欧州はそれぞれ%と%です。中国の割合は2028年には%に達すると予測され、分析期間を通してCAGRは%で推移します。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州のがん免疫調整剤市場については、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
がん免疫調節剤の世界的な主要メーカーには、AbGenomics Corporation、Baxter International、Amgen、ANI Pharmaceuticals、Biovest Internationalなどがあります。2021年、世界の上位5社は売上高で約 %のシェアを占めています。
世界のがん免疫調整剤の範囲とセグメント
がん免疫調整剤市場は、タイプ別および用途別に分類されます。世界のがん免疫調整剤市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
使用方法:CoQ10
使用方法:レバミソールコーティング剤
用途別セグメント
病院
医療機関
会社別
アブジェノミクス株式会社
バクスター・インターナショナル
アムジェン
ANIファーマシューティカルズ
バイオベスト・インターナショナル
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Cancer Immunomodulator Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Immunomodulator Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Method of Use:CoQ10
1.2.3 Method of Use:Levamisole Coating Agent
1.3 Market by Application
1.3.1 Global Cancer Immunomodulator Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Immunomodulator Sales Estimates and Forecasts 2017-2028
2.2 Global Cancer Immunomodulator Revenue Estimates and Forecasts 2017-2028
2.3 Global Cancer Immunomodulator Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cancer Immunomodulator Sales by Region
2.4.1 Global Cancer Immunomodulator Sales by Region (2017-2022)
2.4.2 Global Sales Cancer Immunomodulator by Region (2023-2028)
2.5 Global Cancer Immunomodulator Revenue by Region
2.5.1 Global Cancer Immunomodulator Revenue by Region (2017-2022)
2.5.2 Global Cancer Immunomodulator Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cancer Immunomodulator Sales by Manufacturers
3.1.1 Global Top Cancer Immunomodulator Manufacturers by Sales (2017-2022)
3.1.2 Global Cancer Immunomodulator Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Immunomodulator in 2021
3.2 Global Cancer Immunomodulator Revenue by Manufacturers
3.2.1 Global Cancer Immunomodulator Revenue by Manufacturers (2017-2022)
3.2.2 Global Cancer Immunomodulator Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Immunomodulator Revenue in 2021
3.3 Global Cancer Immunomodulator Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cancer Immunomodulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cancer Immunomodulator Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Immunomodulator Sales by Type
4.1.1 Global Cancer Immunomodulator Historical Sales by Type (2017-2022)
4.1.2 Global Cancer Immunomodulator Forecasted Sales by Type (2023-2028)
4.1.3 Global Cancer Immunomodulator Sales Market Share by Type (2017-2028)
4.2 Global Cancer Immunomodulator Revenue by Type
4.2.1 Global Cancer Immunomodulator Historical Revenue by Type (2017-2022)
4.2.2 Global Cancer Immunomodulator Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cancer Immunomodulator Revenue Market Share by Type (2017-2028)
4.3 Global Cancer Immunomodulator Price by Type
4.3.1 Global Cancer Immunomodulator Price by Type (2017-2022)
4.3.2 Global Cancer Immunomodulator Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cancer Immunomodulator Sales by Application
5.1.1 Global Cancer Immunomodulator Historical Sales by Application (2017-2022)
5.1.2 Global Cancer Immunomodulator Forecasted Sales by Application (2023-2028)
5.1.3 Global Cancer Immunomodulator Sales Market Share by Application (2017-2028)
5.2 Global Cancer Immunomodulator Revenue by Application
5.2.1 Global Cancer Immunomodulator Historical Revenue by Application (2017-2022)
5.2.2 Global Cancer Immunomodulator Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cancer Immunomodulator Revenue Market Share by Application (2017-2028)
5.3 Global Cancer Immunomodulator Price by Application
5.3.1 Global Cancer Immunomodulator Price by Application (2017-2022)
5.3.2 Global Cancer Immunomodulator Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cancer Immunomodulator Market Size by Type
6.1.1 North America Cancer Immunomodulator Sales by Type (2017-2028)
6.1.2 North America Cancer Immunomodulator Revenue by Type (2017-2028)
6.2 North America Cancer Immunomodulator Market Size by Application
6.2.1 North America Cancer Immunomodulator Sales by Application (2017-2028)
6.2.2 North America Cancer Immunomodulator Revenue by Application (2017-2028)
6.3 North America Cancer Immunomodulator Market Size by Country
6.3.1 North America Cancer Immunomodulator Sales by Country (2017-2028)
6.3.2 North America Cancer Immunomodulator Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cancer Immunomodulator Market Size by Type
7.1.1 Europe Cancer Immunomodulator Sales by Type (2017-2028)
7.1.2 Europe Cancer Immunomodulator Revenue by Type (2017-2028)
7.2 Europe Cancer Immunomodulator Market Size by Application
7.2.1 Europe Cancer Immunomodulator Sales by Application (2017-2028)
7.2.2 Europe Cancer Immunomodulator Revenue by Application (2017-2028)
7.3 Europe Cancer Immunomodulator Market Size by Country
7.3.1 Europe Cancer Immunomodulator Sales by Country (2017-2028)
7.3.2 Europe Cancer Immunomodulator Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cancer Immunomodulator Market Size by Type
8.1.1 Asia Pacific Cancer Immunomodulator Sales by Type (2017-2028)
8.1.2 Asia Pacific Cancer Immunomodulator Revenue by Type (2017-2028)
8.2 Asia Pacific Cancer Immunomodulator Market Size by Application
8.2.1 Asia Pacific Cancer Immunomodulator Sales by Application (2017-2028)
8.2.2 Asia Pacific Cancer Immunomodulator Revenue by Application (2017-2028)
8.3 Asia Pacific Cancer Immunomodulator Market Size by Region
8.3.1 Asia Pacific Cancer Immunomodulator Sales by Region (2017-2028)
8.3.2 Asia Pacific Cancer Immunomodulator Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cancer Immunomodulator Market Size by Type
9.1.1 Latin America Cancer Immunomodulator Sales by Type (2017-2028)
9.1.2 Latin America Cancer Immunomodulator Revenue by Type (2017-2028)
9.2 Latin America Cancer Immunomodulator Market Size by Application
9.2.1 Latin America Cancer Immunomodulator Sales by Application (2017-2028)
9.2.2 Latin America Cancer Immunomodulator Revenue by Application (2017-2028)
9.3 Latin America Cancer Immunomodulator Market Size by Country
9.3.1 Latin America Cancer Immunomodulator Sales by Country (2017-2028)
9.3.2 Latin America Cancer Immunomodulator Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cancer Immunomodulator Market Size by Type
10.1.1 Middle East and Africa Cancer Immunomodulator Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cancer Immunomodulator Revenue by Type (2017-2028)
10.2 Middle East and Africa Cancer Immunomodulator Market Size by Application
10.2.1 Middle East and Africa Cancer Immunomodulator Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cancer Immunomodulator Revenue by Application (2017-2028)
10.3 Middle East and Africa Cancer Immunomodulator Market Size by Country
10.3.1 Middle East and Africa Cancer Immunomodulator Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cancer Immunomodulator Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbGenomics Corporation
11.1.1 AbGenomics Corporation Corporation Information
11.1.2 AbGenomics Corporation Overview
11.1.3 AbGenomics Corporation Cancer Immunomodulator Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbGenomics Corporation Cancer Immunomodulator Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbGenomics Corporation Recent Developments
11.2 Baxter International
11.2.1 Baxter International Corporation Information
11.2.2 Baxter International Overview
11.2.3 Baxter International Cancer Immunomodulator Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter International Cancer Immunomodulator Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter International Recent Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Overview
11.3.3 Amgen Cancer Immunomodulator Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Amgen Cancer Immunomodulator Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Amgen Recent Developments
11.4 ANI Pharmaceuticals
11.4.1 ANI Pharmaceuticals Corporation Information
11.4.2 ANI Pharmaceuticals Overview
11.4.3 ANI Pharmaceuticals Cancer Immunomodulator Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 ANI Pharmaceuticals Cancer Immunomodulator Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 ANI Pharmaceuticals Recent Developments
11.5 Biovest International
11.5.1 Biovest International Corporation Information
11.5.2 Biovest International Overview
11.5.3 Biovest International Cancer Immunomodulator Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biovest International Cancer Immunomodulator Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biovest International Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Immunomodulator Industry Chain Analysis
12.2 Cancer Immunomodulator Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Immunomodulator Production Mode & Process
12.4 Cancer Immunomodulator Sales and Marketing
12.4.1 Cancer Immunomodulator Sales Channels
12.4.2 Cancer Immunomodulator Distributors
12.5 Cancer Immunomodulator Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cancer Immunomodulator Industry Trends
13.2 Cancer Immunomodulator Market Drivers
13.3 Cancer Immunomodulator Market Challenges
13.4 Cancer Immunomodulator Market Restraints
14 Key Findings in The Global Cancer Immunomodulator Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer